Adicet Bio (ACET) vs Boundless Bio (BOLD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Boundless Bio (BOLD) has outperformed Adicet Bio (ACET) over the past year, gaining 114.6% versus a loss of 54.7%. Boundless Bio is the larger company by market cap ($60.5 million vs $56.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACET | BOLD |
|---|---|---|
| Share price | $6.02 | $2.66 |
| Market cap | $56.36M | $60.51M |
| 1-day change | -2.58% | +0.76% |
| YTD return | -26.60% | +120.00% |
| 1-year return | -54.72% | +114.63% |
| 5-year return | -95.20% | — |
| EPS (TTM) | $-10.42 | $-2.85 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.44 | $3.16 |
| 52-week low | $6.01 | $0.961 |
| Distance from 52-week high | -65.48% | -15.93% |
| Average volume | 166.29K | 179.14K |
| Shares outstanding | 9.36M | 22.75M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BOLD has outperformed ACET by 169.4 percentage points over the past year.
ACET vs BOLD FAQ
Which is bigger, Adicet Bio or Boundless Bio?
Boundless Bio (BOLD) is larger, with a market capitalization of $60.51M compared with $56.36M for Adicet Bio (ACET).
Which stock has performed better over the past year, ACET or BOLD?
BOLD returned +114.63% over the past 12 months, compared with -54.72% for ACET (price return, excluding dividends). Past performance does not predict future results.
Are Adicet Bio and Boundless Bio in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.